Abhijit Y. Talwalkar, a director at Lam Research Corp. (NASDAQ:LRCX), executed a sale of 18,282 shares of the company's common stock on July 13, 2026. The transaction was valued at approximately $6,124,470, with each share sold at $335.00. This sale was carried out under a Rule 10b5-1 trading plan that Talwalkar established on March 11, 2026. Following this transaction, Talwalkar's direct ownership of Lam Research common stock stands at 87,142 shares, a figure that includes unvested restricted stock units.
The sale occurs against a backdrop of significant stock appreciation, with Lam Research shares having surged 233% over the past year. As of the reporting period, the stock was trading at $346.76, corresponding to a market capitalization of $433 billion. Market analysis suggests the stock may be overvalued relative to its Fair Value, although the company retains a perfect Piotroski Score of 9, indicating robust financial health.
Concurrently, several analysts have raised their price targets for Lam Research, reflecting positive expectations for the company's future performance. Stifel increased its price target to $425, maintaining a Buy rating, and anticipates Lam Research will exceed its fiscal fourth-quarter estimates, with projected system revenue of $4.6 billion. Mizuho also raised its price target to $400, citing strong demand for AI chips that supports a durable increase in wafer fabrication equipment estimates for the coming years. Similarly, TD Cowen adjusted its target to $400, driven by a robust outlook for worldwide front-end equipment spending, which could reach $250 billion by 2028. Lynx Equity raised its target to $400 as well, noting increased wafer fabrication equipment estimates and a significant rise in Lam Research's projected 2028 revenue and earnings per share. Additionally, Cantor Fitzgerald increased its price target for KLA Corporation to $325, highlighting potential earnings per share growth in the semiconductor equipment sector.